West Pharma (WST) Cash Flow Statement

Click line-items for a historical chart and %

Net income	104.5M
Depreciation	65.9M
Amortization	2M
Other non-cash items, net	-3.7M
Changes in assets and liabilities
Net cash provided by operating activities	147.6M
Capital expenditures	-122.7M
Acquisition of business, net of cash acquired
Acquisition of patents and other long-term assets
Purchases of investments, net
Other, net	2M
Net cash used in investing activities	-129.1M
Borrowings under revolving credit agreements, net
Repayment of former credit facility
Debt issuance costs
Changes in other debt
Dividend payments	-26.2M
Excess tax benefit from employee stock plans
Shares repurchased for employee tax withholdings	-26.8M
Issuance of common stock from treasury
Net cash used in financing activities	-87.5M
Effect of exchange rates on cash	300K
Net increase (decrease) in cash and cash equivalents	-68.7M
Cash, including cash equivalents at beginning of period	274.6M
Cash, including cash equivalents at end of period	205.9M

Entities mentioned with WST

View All Entities